Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer’s disease
Author(s) -
Ihab Hajjar,
Maureen Okafor,
Limeng Wan,
Zhiyi Yang,
Jonathon A. Nye,
Anastasia Bohsali,
Leslie M. Shaw,
Allan I. Levey,
James J. Lah,
Vince D. Calhoun,
Reneé H. Moore,
Felicia C. Goldstein
Publication year - 2022
Publication title -
brain communications
Language(s) - English
Resource type - Journals
ISSN - 2632-1297
DOI - 10.1093/braincomms/fcac270
Subject(s) - candesartan , biomarker , disease , medicine , alzheimer's disease , oncology , receptor , biology , angiotensin ii , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom